In the US, Armodafinil (armodafinil systemic) is a member of the drug class CNS stimulants and is used to treat ADHD, Bipolar Disorder, Chronic Fatigue Syndrome, Depression, Hypersomnia, Jet Lag, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome and Shift Work Sleep Disorder.
US matches:
- Armodafinil
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0112111-43-0
Chemical Formula
C15-H15-N-O2-S
Molecular Weight
273
Therapeutic Categories
Central stimulant
Drug acting on the central nervous system
α-Sympathomimetic agent
Chemical Names
(-)-2-((R)-(Diphenylmethyl)sulfinyl)acetamide
2-[(R)-(Diphenylmethyl)sulfinyl])acetamid (IUPAC)
2-[(R)-(Diphenylmethyl)sulfinyl])acetamide (WHO)
Acetamide, 2-((diphenylmethyl)sulfinyl)-, (-)-
Foreign Names
- Armodafinilum (Latin)
- Armodafinil (German)
- Armodafinil (French)
- Armodafinilo (Spanish)
Generic Names
- Armodafinil (OS: USAN)
- (-)-Modafinil (IS)
- (R)-(-)Modafinil (IS)
- CEP 10953 (IS)
- CRL 40982 (IS)
- Modafinil-R isomer (IS)
- R-Modafinil (IS: Cephalon)
Brand Name
- Nuvigil
Cephalon, United States
International Drug Name Search
Glossary
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment